Moreover, the expression levels of FOSL1 gene was elevated in mesenchymal subtypes across four cohorts including The Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), CHA, and PRJNA1051047 (Figure S1C). This evidence concerns the gene FOSL1 and central nervous system cancer.